Global Dual Antibody ADC Industry

2025-2031 Global Dual-Antibody ADC Industry Research & Trends Analysis Report

Global Dual Antibody ADC Industry

2025-2031 Global Dual-Antibody ADC Industry Research & Trends Analysis Report

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Market IntelliX Study, the global market for Dual-Antibody ADC should grow from US$ 561 million in 2025 to US$ 752 million by 2031, with a CAGR of 5.40% for the period of 2025 -2031.

Dual-Antibody ADC Market Overview
Dual-Antibody ADC is an innovative targeted therapy that combines a bispecific antibody with a cytotoxic payload, enabling simultaneous recognition of two tumor-associated antigens and precise delivery of potent toxins to cancer cells. Compared to conventional ADCs, dual-antibody ADCs exhibit enhanced tumor selectivity and reduced off-target toxicity, potentially improving therapeutic efficacy while minimizing side effects. These drugs show promising applications in both hematological malignancies and solid tumors, representing a cutting-edge research focus in targeted cancer therapy.

Key Insights & Strategic Takeaways Driving Market Outlook

(1) Global Dual-Antibody ADC market size (sales volume & revenue), history data from 2020 - 2025, and forecast data from {2025 to 2031.

(2) Global Dual-Antibody ADC market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Dual-Antibody ADC market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Dual-Antibody ADC segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Dual-Antibody ADC segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Dual-Antibody ADC , capacity, production and trends.

(7) Dual-Antibody ADC industry supply chain, upstream, midstream, and downstream analysis.

In-Depth Assessment of Market Segmentation by Geographic Region

➤ North America (United States, Canada, and Mexico)
➤ Europe (UK, Germany, France, Russia, and Italy)
➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
➤ South America (Brazil, Colombia, Argentina, etc.)
➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)

Segmentation by Product Type: Analytical Breakdown and Market Relevance
This section presents a comprehensive analysis of the market based on product type, highlighting segment-wise performance indicators, emerging trends, and their strategic implications within the overall industry landscape.
  • Solid Tumors
  • Non-Solid Tumors

Market Segmentation by Application
Markets are categorized based on specific application areas, offering insight into usage trends and consumer preferences. This segmentation helps businesses tailor products, services, and strategies to align with diverse industry needs and customer demands.
  • Dual-Target ADC
  • Dual-Epitope ADC

Market Segmentation by Key Players
This report examines the competitive landscape by categorizing market participants based on their roles, influence, and strategic positioning. Understanding player segmentation helps identify industry leaders, emerging competitors, and collaboration opportunities within the market.
  • Sichuan Biokin Pharmaceutical
  • Doma Biopharmaceutical
  • VelaVigo
  • Hangzhou DAC Biotechnology
  • Biocy Togen
  • Innovent Biologics
  • Zymeworks
  • AstraZeneca
  • Regeneron Pharmaceuticals
  • Sutro Biopharma/Merck
  • Alphamab Oncology
  • Coherent Biopharma
  • Sichuan Kelun Pharmaceutical
  • Akeso

1 Market Overview

1.1 Product Overview and Scope of Dual-Antibody ADC

1.2 Global Dual-Antibody ADC Market Size and Forecast

1.3 China Dual-Antibody ADC Market Size and Forecast

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Dual-Antibody ADC Share in Global Market, 2020-2031

1.4.2 Dual-Antibody ADC Market Size: China VS Global, 2020-2031

1.5 Dual-Antibody ADC Market Dynamics

1.5.1 Dual-Antibody ADC Market Drivers

1.5.2 Dual-Antibody ADC Market Restraints

1.5.3 Dual-Antibody ADC Industry Trends

1.5.4 Dual-Antibody ADC Industry Policy

2 Competitive Landscape by Company

2.1 Global Dual-Antibody ADC Revenue by Company, 2020-2025

2.2 Global Dual-Antibody ADC Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Dual-Antibody ADC Concentration Ratio

2.4 Global Dual-Antibody ADC Mergers & Acquisitions, Expansion Plans

2.5 Global Dual-Antibody ADC Manufacturers Product Type

2.6 Global Geographic Distribution of Dual-Antibody ADC Companies

3 China Competitive Situation by Company

3.1 China Dual-Antibody ADC Revenue by Company, 2020-2025

3.2 China Dual-Antibody ADC Dual-Antibody ADC Participants, Market Position (Tier 1, Tier 2, and Tier 3)

3.3 China Dual-Antibody ADC Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis

4.1 Dual-Antibody ADC Industry Chain

4.2 Dual-Antibody ADC Upstream Analysis

4.3 Dual-Antibody ADC Midstream Analysis

4.4 Dual-Antibody ADC Downstream Analysis

5 Sights by Type

5.1 Dual-Antibody ADC Classification

5.1.1 Dual-Target ADC

5.1.2 Dual-Epitope ADC

5.2 by Type, Global Dual-Antibody ADC Market Size & CAGR, 2020 VS 2024 VS 2031

5.3 by Type, Global Dual-Antibody ADC Market Size, 2020-2031

6 Sights by Application

6.1 Dual-Antibody ADC Segment by Application

6.1.1 Solid Tumors

6.1.2 Non-Solid Tumors

6.2 by Application, Global Dual-Antibody ADC Market Size & CAGR, 2020 VS 2024 VS 2031

6.3 by Application, Global Dual-Antibody ADC Market Size, 2020-2031

7 Sights by Region

7.1 By Region, Global Dual-Antibody ADC Market Size, 2020 VS 2024 VS 2031

7.2 By Region, Global Dual-Antibody ADC Market Size, 2020-2031

7.3 North America

7.3.1 North America Dual-Antibody ADC Market Size & Forecasts, 2020-2031

7.3.2 By Country, North America Dual-Antibody ADC Market Size Market Share

7.4 Europe

7.4.1 Europe Dual-Antibody ADC Market Size & Forecasts, 2020-2031

7.4.2 By Country, Europe Dual-Antibody ADC Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Dual-Antibody ADC Market Size & Forecasts, 2020-2031

7.5.2 By Country/Region, Asia Pacific Dual-Antibody ADC Market Size Market Share

7.6 South America

7.6.1 South America Dual-Antibody ADC Market Size & Forecasts, 2020-2031

7.6.2 By Country, South America Dual-Antibody ADC Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Dual-Antibody ADC Market Size & CAGR，2020 VS 2024 VS 2031

8.2 By Country, Global Dual-Antibody ADC Market Size, 2020-2031

8.3 United States

8.3.1 United States Dual-Antibody ADC Market Size, 2020-2031

8.3.2 By Company, United States Dual-Antibody ADC Revenue Market Share, 2024

8.3.3 by Type, United States Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.3.4 by Application, United States Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.4 Europe

8.4.1 Europe Dual-Antibody ADC Market Size, 2020-2031

8.4.2 By Company, Europe Dual-Antibody ADC Revenue Market Share, 2024

8.4.3 by Type, Europe Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.4.4 by Application, Europe Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.5 China

8.5.1 China Dual-Antibody ADC Market Size, 2020-2031

8.5.2 By Company, China Dual-Antibody ADC Revenue Market Share, 2024

8.5.3 by Type, China Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.5.4 by Application, China Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.6 Japan

8.6.1 Japan Dual-Antibody ADC Market Size, 2020-2031

8.6.2 By Company, Japan Dual-Antibody ADC Revenue Market Share, 2024

8.6.3 by Type, Japan Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.6.4 by Application, Japan Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Dual-Antibody ADC Market Size, 2020-2031

8.7.2 By Company, South Korea Dual-Antibody ADC Revenue Market Share, 2024

8.7.3 by Type, South Korea Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.7.4 by Application, South Korea Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Dual-Antibody ADC Market Size, 2020-2031

8.8.2 By Company, Southeast Asia Dual-Antibody ADC Revenue Market Share, 2024

8.8.3 by Type, Southeast Asia Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.8.4 by Application, Southeast Asia Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.9 India

8.9.1 India Dual-Antibody ADC Market Size, 2020-2031

8.9.2 By Company, India Dual-Antibody ADC Revenue Market Share, 2024

8.9.3 by Type, India Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.9.4 by Application, India Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.10 Middle East & Africa

8.10.1 Middle East & Africa Dual-Antibody ADC Market Size, 2020-2031

8.10.2 By Company, Middle East & Africa Dual-Antibody ADC Revenue Market Share, 2024

8.10.3 by Type, Middle East & Africa Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

8.10.4 by Application, Middle East & Africa Dual-Antibody ADC Revenue Market Share, 2024 VS 2031

9 Company Profile

9.1 Sichuan Biokin Pharmaceutical

9.1.1 Sichuan Biokin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

9.1.2 Sichuan Biokin Pharmaceutical Company Profile and Main Business

9.1.3 Sichuan Biokin Pharmaceutical Dual-Antibody ADC Models, Specifications, and Application

9.1.4 Sichuan Biokin Pharmaceutical Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.1.5 Sichuan Biokin Pharmaceutical Recent Developments

9.2 Doma Biopharmaceutical

9.2.1 Doma Biopharmaceutical Company Information, Head Office, Market Area, and Industry Position

9.2.2 Doma Biopharmaceutical Company Profile and Main Business

9.2.3 Doma Biopharmaceutical Dual-Antibody ADC Models, Specifications, and Application

9.2.4 Doma Biopharmaceutical Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.2.5 Doma Biopharmaceutical Recent Developments

9.3 VelaVigo

9.3.1 VelaVigo Company Information, Head Office, Market Area, and Industry Position

9.3.2 VelaVigo Company Profile and Main Business

9.3.3 VelaVigo Dual-Antibody ADC Models, Specifications, and Application

9.3.4 VelaVigo Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.3.5 VelaVigo Recent Developments

9.4 Hangzhou DAC Biotechnology

9.4.1 Hangzhou DAC Biotechnology Company Information, Head Office, Market Area, and Industry Position

9.4.2 Hangzhou DAC Biotechnology Company Profile and Main Business

9.4.3 Hangzhou DAC Biotechnology Dual-Antibody ADC Models, Specifications, and Application

9.4.4 Hangzhou DAC Biotechnology Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.4.5 Hangzhou DAC Biotechnology Recent Developments

9.5 Biocy Togen

9.5.1 Biocy Togen Company Information, Head Office, Market Area, and Industry Position

9.5.2 Biocy Togen Company Profile and Main Business

9.5.3 Biocy Togen Dual-Antibody ADC Models, Specifications, and Application

9.5.4 Biocy Togen Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.5.5 Biocy Togen Recent Developments

9.6 Innovent Biologics

9.6.1 Innovent Biologics Company Information, Head Office, Market Area, and Industry Position

9.6.2 Innovent Biologics Company Profile and Main Business

9.6.3 Innovent Biologics Dual-Antibody ADC Models, Specifications, and Application

9.6.4 Innovent Biologics Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.6.5 Innovent Biologics Recent Developments

9.7 Zymeworks

9.7.1 Zymeworks Company Information, Head Office, Market Area, and Industry Position

9.7.2 Zymeworks Company Profile and Main Business

9.7.3 Zymeworks Dual-Antibody ADC Models, Specifications, and Application

9.7.4 Zymeworks Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.7.5 Zymeworks Recent Developments

9.8 AstraZeneca

9.8.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position

9.8.2 AstraZeneca Company Profile and Main Business

9.8.3 AstraZeneca Dual-Antibody ADC Models, Specifications, and Application

9.8.4 AstraZeneca Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.8.5 AstraZeneca Recent Developments

9.9 Regeneron Pharmaceuticals

9.9.1 Regeneron Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

9.9.2 Regeneron Pharmaceuticals Company Profile and Main Business

9.9.3 Regeneron Pharmaceuticals Dual-Antibody ADC Models, Specifications, and Application

9.9.4 Regeneron Pharmaceuticals Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.9.5 Regeneron Pharmaceuticals Recent Developments

9.10 Sutro Biopharma/Merck

9.10.1 Sutro Biopharma/Merck Company Information, Head Office, Market Area, and Industry Position

9.10.2 Sutro Biopharma/Merck Company Profile and Main Business

9.10.3 Sutro Biopharma/Merck Dual-Antibody ADC Models, Specifications, and Application

9.10.4 Sutro Biopharma/Merck Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.10.5 Sutro Biopharma/Merck Recent Developments

9.11 Alphamab Oncology

9.11.1 Alphamab Oncology Company Information, Head Office, Market Area, and Industry Position

9.11.2 Alphamab Oncology Company Profile and Main Business

9.11.3 Alphamab Oncology Dual-Antibody ADC Models, Specifications, and Application

9.11.4 Alphamab Oncology Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.11.5 Alphamab Oncology Recent Developments

9.12 Coherent Biopharma

9.12.1 Coherent Biopharma Company Information, Head Office, Market Area, and Industry Position

9.12.2 Coherent Biopharma Company Profile and Main Business

9.12.3 Coherent Biopharma Dual-Antibody ADC Models, Specifications, and Application

9.12.4 Coherent Biopharma Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.12.5 Coherent Biopharma Recent Developments

9.13 Sichuan Kelun Pharmaceutical

9.13.1 Sichuan Kelun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

9.13.2 Sichuan Kelun Pharmaceutical Company Profile and Main Business

9.13.3 Sichuan Kelun Pharmaceutical Dual-Antibody ADC Models, Specifications, and Application

9.13.4 Sichuan Kelun Pharmaceutical Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.13.5 Sichuan Kelun Pharmaceutical Recent Developments

9.14 Akeso

9.14.1 Akeso Company Information, Head Office, Market Area, and Industry Position

9.14.2 Akeso Company Profile and Main Business

9.14.3 Akeso Dual-Antibody ADC Models, Specifications, and Application

9.14.4 Akeso Dual-Antibody ADC Revenue and Gross Margin, 2020-2025

9.14.5 Akeso Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Dual-Antibody ADC Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Dual-Antibody ADC Market trending toward high growth trajectories?
A dynamic process in the Dual-Antibody ADC Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Sichuan Biokin Pharmaceutical Doma Biopharmaceutical VelaVigo Hangzhou DAC Biotechnology Biocy Togen Innovent Biologics Zymeworks AstraZeneca Regeneron Pharmaceuticals Sutro Biopharma/Merck Alphamab Oncology Coherent Biopharma Sichuan Kelun Pharmaceutical Akeso.
How competitive is the Dual-Antibody ADC Market going to be?
The strategic moves of the Dual-Antibody ADC Market players such as Sichuan Biokin Pharmaceutical Doma Biopharmaceutical VelaVigo Hangzhou DAC Biotechnology Biocy Togen Innovent Biologics Zymeworks AstraZeneca Regeneron Pharmaceuticals Sutro Biopharma/Merck Alphamab Oncology Coherent Biopharma Sichuan Kelun Pharmaceutical Akeso, and others clearly highlight consumer-centric strategies that use technology to improve customer experience.
What important business segments are segregated by application types in the latest edition of the Dual-Antibody ADC Market?
The key business segments in the Dual-Antibody ADC Market are segregated by applications [Dual-Target ADC Dual-Epitope ADC] and types [Solid Tumors Non-Solid Tumors].
What is the estimated size & growth rate of the Dual-Antibody ADC Market?
In recent years, the Dual-Antibody ADC Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
What are the underlying opportunities in the Dual-Antibody ADC Market?
The influx of capital into the Dual-Antibody ADC Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
Who should consider the Dual-Antibody ADC Market study?
The Dual-Antibody ADC Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.